Sign up to save your podcasts
Or
Share #204 NephMadness 2020: SGLT2 Inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#204 NephMadness 2020: SGLT2 Inhibitors
Get under the hood of SGLT2 inhibitors! Listen as our guests Dr. Harish Seethapathy, Dr. Matt Sparks, and Dr. Joel Topf give us a tour through the NephMadness 2020 SGLT2i region! How do these promising drugs work, and what evidence is there for using them in non-diabetic kidney disease or kidney transplant patients. Show Notes | Spotify | Swag! | Top Picks | Mailing List | [email protected]
Credits
Sponsor: McGraw Hill
Time Stamps
00:00 Sponsor
00:26 Intro, disclaimer, guest bio
02:57 Guest one-liner and Picks of the Week*: Michael Pollan audiobook on Coffee and Caffeine Addiction
03:52 SGLT2i definition, background, and why we now consider CV endpoints in diabetes
11:16 Sponsor
12:00 Tubuloglomerular feedback; Balloon analogy
17:40 Other mechanisms for SGLT2i
23:05 Back to the case; Risks from SGLT2i; Counseling and Monitoring
34:18 SGLT2i for non-diabetic kidney disease; Possible mechanisms: Joel’s caution against early adoption
41:42 SGLT2 inhibitors in kidney transplant
45:20 Take home points and picks for the SGLT2 inhibitor region
49:50 Outro
View all episodes
By The Curbsiders Internal Medicine Podcast
4.8
31783,178 ratings
Get under the hood of SGLT2 inhibitors! Listen as our guests Dr. Harish Seethapathy, Dr. Matt Sparks, and Dr. Joel Topf give us a tour through the NephMadness 2020 SGLT2i region! How do these promising drugs work, and what evidence is there for using them in non-diabetic kidney disease or kidney transplant patients. Show Notes | Spotify | Swag! | Top Picks | Mailing List | [email protected]
Credits
Sponsor: McGraw Hill
Time Stamps
00:00 Sponsor
00:26 Intro, disclaimer, guest bio
02:57 Guest one-liner and Picks of the Week*: Michael Pollan audiobook on Coffee and Caffeine Addiction
03:52 SGLT2i definition, background, and why we now consider CV endpoints in diabetes
11:16 Sponsor
12:00 Tubuloglomerular feedback; Balloon analogy
17:40 Other mechanisms for SGLT2i
23:05 Back to the case; Risks from SGLT2i; Counseling and Monitoring
34:18 SGLT2i for non-diabetic kidney disease; Possible mechanisms: Joel’s caution against early adoption
41:42 SGLT2 inhibitors in kidney transplant
45:20 Take home points and picks for the SGLT2 inhibitor region
49:50 Outro
More shows like The Curbsiders Internal Medicine Podcast
View all
AFP: American Family Physician Podcast
695 Listeners
JAMA Clinical Reviews
496 Listeners
Core EM - Emergency Medicine Podcast
251 Listeners
Mayo Clinic Talks
291 Listeners
Frankly Speaking About Family Medicine
260 Listeners
Core IM | Internal Medicine Podcast
1,153 Listeners
Annals On Call Podcast
195 Listeners
The Internet Book of Critical Care Podcast
703 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
365 Listeners
Run the List
252 Listeners
Cardionerds: A Cardiology Podcast
432 Listeners
The Curious Clinicians
369 Listeners
The Cribsiders
314 Listeners
Critical Care Time
234 Listeners